Cambridge Cognition (LON:COG) Sets New 1-Year Low at $23.92

Cambridge Cognition Holdings PLC (LON:COG) shares hit a new 52-week low on Thursday . The stock traded as low as GBX 23.92 ($0.31) and last traded at GBX 26 ($0.34), with a volume of 17616 shares. The stock had previously closed at GBX 27 ($0.35).

Separately, FinnCap reiterated a “corporate” rating on shares of Cambridge Cognition in a research note on Tuesday, August 27th.

The firm has a market cap of $6.28 million and a price-to-earnings ratio of -3.71. The firm’s 50 day moving average price is GBX 54.91 and its two-hundred day moving average price is GBX 67.32.



Cambridge Cognition Company Profile (LON:COG)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health products. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from phases I–IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.

Featured Story: Is a Roth IRA right for you?

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.